Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 14, 2012

View Archived Issues

New therapeutic target identified for schizophrenia

Nanoparticles targeting microRNA inhibit lymphoma

Novo Nordisk announces highlights of second quarter 2012

MultiCell Technologies updates on candidate dsRNA anticancer therapies

Protalix BioTherapeutics to begin clinical testing of candidate Fabry's disease drug

Bionor Pharma to conduct HIV vaccine combination study

AspenBio Pharma submits pre-IDE package for appendicitis test

Biofrontera and Pelpharma Handels sign distribution agreement

Scientists in China isolate new saponins from bunge fruit

Canadian university patents novel melanocortin MC4 receptor modulators

Compounds for ADHD treatment synthesized in France

New glutamate receptor antagonists presented by Taisho Pharmaceutical

Novel calcium channel antagonists developed at U.S. university

Nagasaki University reports new candidate anticancer products

Meritage Pharma launches trial in eosinophilic esophagitis

Recruitment complete in first stage of TACTT1 study

FDA extends PDUFA action date for Gattex NDA

Novel HCV entry inhibitor selected for further evaluation

New E.U. approval for Votrient

Second-generation Shigella vaccines designed in U.S.

PDUFA date for Santarus NDA extended

Tarceva approved in Canada for specific NSCLC subtype

FDA accepts for filing Teva's NDA for new oral contraceptive

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...